A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients

  • 0Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, China.

|

|

Summary

This summary is machine-generated.

A new prognostic model integrating inflammation, nutrition, and clinical data accurately predicts breast cancer survival. This tool enhances personalized treatment strategies for breast cancer (BC) patients.

Area Of Science

  • Oncology
  • Biostatistics

Background

  • Breast cancer (BC) prognosis requires improved predictive models.
  • Current models may not fully integrate inflammatory and nutritional markers.

Purpose Of The Study

  • To develop and validate a novel prognostic nomogram for breast cancer (BC).
  • To incorporate inflammation, nutritional parameters, and clinicopathological features for predicting overall survival (OS) and disease-free survival (DFS).

Main Methods

  • Utilized data from 2857 BC patients (2013-2021), divided into training (n=2001) and validation (n=856) cohorts.
  • Developed a nomogram using multivariate Cox regression analysis.
  • Evaluated predictive accuracy and discrimination using concordance index (C-index) and calibration curves.
  • Assessed clinical utility via decision curve analysis (DCA).

Main Results

  • The developed nomogram incorporates lymphocyte count, platelet count, hemoglobin, albumin-to-globulin ratio, prealbumin, subtype, and TNM staging.
  • The nomogram demonstrated a statistically superior C-index for predicting OS and DFS compared to TNM staging alone.
  • Time-dependent AUC exceeded 0.7, indicating satisfactory discriminative performance.
  • DCA showed greater overall net benefit for the nomogram compared to TNM staging.

Conclusions

  • The nomogram integrating inflammation, nutritional, and clinicopathological variables shows excellent discrimination.
  • This tool is promising for predicting BC patient outcomes.
  • It can aid in defining personalized treatment strategies for breast cancer.